Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research

for long-term success. Elizabeth has also supported global Phase 3 programs, built scalable proposal frameworks and helped advance partnerships moving early-stage science into clinical development. "The best clinical organizations aren't built on...

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

same efficacy and safety profile as the original formulation offered in a smaller pill.1-3 The product has been renamed to help patients and healthcare professionals more easily recognize the available treatment options for type 2 diabetes that...

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

Cancer Medicine at The University of Texas MD Anderson Cancer Center. “Since its initial approval in 2011, ruxolitinib has helped transform the treatment landscape for patients with MPNs and GVHD. With the approval of Jakafi XR, appropriate...

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

including development, launch, and commercialization, will enable the continuation of our clinical programs and help deliver on the potential for our pipeline.” Under the terms of the agreement, UCB will pay US $2 billion upfront payments and up to...

TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

With the launch of Addyi, the first ever FDA-approved treatment for Hypoactive Sexual Desire Disorder (HSDD), Sprout helped shift the conversation around women's sexual wellness. The company remains committed to advancing science, expanding access,...

Pharmacists gain a flexible, space-saving option as YARAL Pharma launches its 15-count Diclofenac Epolamine Topical System 1.3%

in a 15-count carton. Designed to meet the operational needs of today’s pharmacies, the new 15-count configuration helps pharmacists reduce clutter, optimize storage space, and manage inventory with greater flexibility, while continuing to provide...

Lasix® ONYU® Receives CE Marking, Advancing Toward International Authorization; EMA Approves for Centralized Review Based on Innovation

blood pressure temporarily. You may feel lightheaded or dizzy. This usually happens when you stand. Getting up slowly may help. High Blood Sugar: Lasix ONYU may increase blood sugar (glucose) levels if you have diabetes mellitus. Loss of Hearing:...

Rapid Nexus Secures VA and DoD Contracts, Launches Commercial Deployment of FDA-Cleared Wound Technology

The presence of multiple repair pathways activating simultaneously suggests a broader biological response that may help explain the tissue recovery observed in prior clinical findings. "This is an important step as we move from research and...

Apertura Gene Therapy and Broad Institute scientists share data on TfR1 CapX™, a novel CNS-targeting capsid

in Boston, MA. Data presented by Apertura at ASGCT show that TfR1 CapX can be manufactured at clinically relevant scale, helping reduce one of the biggest bottlenecks in bringing therapies to patients. The company will also present on the utility...

AbbVie submits FDA application for SKYRIZI® (risankizumab-rzaa) subcutaneous induction in adults with moderate to severe Crohn’s disease

head of immunology clinical development, AbbVie. "AbbVie continues to invest in research and innovative solutions to help elevate the standard of care for patients so that they may live a life unburdened by their Crohn's disease." The application...

OrthoTrophix reports new findings on TPX-100, revealing a structural relationship between femoral bone shape and meniscal pathology in knee osteoarthritis

a subgroup of patients with reduced placebo responsiveness and greater treatment separation. Meniscal disease burden may help identify patients who are especially likely to benefit from TPX-100. "These data provide new insight into the relationship...

“O’Shaughnessy Ventures supports scientist uncovering biology’s hidden communication system

interest in all things art, science, investing and technology with his long-held desire to establish scenarios designed to help promising creators and their inspiring ideas succeed, regardless of age, location, job history or level of education.

Bristol Myers Squibb and Pfizer to provide Eliquis® (apixaban) through the Mark Cuban Cost Plus Drug Company

lungs (pulmonary embolism – PE), and reduce the risk of them occurring again after receiving treatment for blood clots - Help prevent a blood clot in the legs (DVT) and lungs (PE) of people who have just had hip or knee replacement surgery...

CRENESSITY® lowers glucocorticoid doses while maintaining androgen control in adults with classic congenital adrenal hyperplasia

swelling of the lips, tongue, or face, and rash. If you have an allergic reaction to CRENESSITY, get emergency medical help right away and stop taking CRENESSITY. Risk of Sudden Adrenal Insufficiency or Adrenal Crisis with Too Little Glucocorticoid...

Avantor® Expands Stability and Microbial Testing Facility to Enhance U.S. Biomanufacturing Infrastructure

our quality control capabilities in North America strengthens our manufacturing and supply chain infrastructure and will help us deliver our high-quality chemicals and other products to customers faster," said Mary Blenn, Chief Operating Officer at...

Recent Innovations Showcased by Baxter

Solutions at Baxter. “Through close collaboration with healthcare professionals, we consistently evolve our portfolio to help enhance efficiency and support safer care across hospital settings. The new portfolio additions we’re exhibiting at AORN...

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Lilly. "We're committed to expanding access to treatment options through channels that meet patients where they are and help them achieve their weight loss goals." Ro's obesity care formulary is one the most comprehensive of any telehealth company,...

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

beat-to-beat arterial waveform data from a noninvasive finger cuff directly to compatible multiparameter patient monitors, helping clinicians close gaps between intermittent readings. "We're delivering real-time visibility of hemodynamic changes to...

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

Curve Biosciences is advancing innovative approaches designed to shift that paradigm. I am excited to join the team and help translate scientific innovation into practical tools that can improve survival and quality of life for patients with liver...

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

invasive, long-lifetime “read/write” brain-computer interface (BCI) with assistive devices and AI-driven support to help stroke survivors translate neural intent into functional movement and daily independence. Epia Neuro is advancing towards...